Thyroid Eye Disease Treatments Market

Thyroid eye disease is the inflammation of the eye muscles, eyelids, tear glands and fatty tissues behind the eye. The inflammation leads to swelling of the eye, eyes and eyelids become red and eye ca be pushed forward. The movement of the eye also affects, as both eyes do not move in sync which may result in the double vision. Thyroid eye disease also known as Graves? Orbitopathy or Ophthalmopathy which is an autoimmune condition, this condition often affects thyroid gland and makes it hyperactive in most of the cases. The thyroid eye disease can affect anybody whose thyroid gland is overactive or underactive or even functioning normally. Around 25% of people with graves? disease can develop thyroid eye disease.

Thyroid Eye Disease Treatments Market contains market size and forecasts of Thyroid Eye Disease Treatments in Global, including the following market information:

Global Thyroid Eye Disease Treatments Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Thyroid Eye Disease Treatments market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Medication Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Thyroid Eye Disease Treatments include Bausch And Lomb Inc, Kala Pharmaceuticals Inc, Pharmos Corp, Hi-Tech Pharmacal Co Inc, Allergan plc, Novartis AG, Eyevance Pharmaceuticals LLC, Pfizer Inc and Horizon Therapeutics plc. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Thyroid Eye Disease Treatments companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Thyroid Eye Disease Treatments Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Thyroid Eye Disease Treatments Market Segment Percentages, by Type, 2021 (%)

Medication

Radioactive Iodine Therapy

Surgery

Global Thyroid Eye Disease Treatments Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Thyroid Eye Disease Treatments Market Segment Percentages, by Application, 2021 (%)

Surgery Hospital Pharmacy

Online Pharmacy

Retail Pharmacy

Global Thyroid Eye Disease Treatments Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Thyroid Eye Disease Treatments Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Thyroid Eye Disease Treatments revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Thyroid Eye Disease Treatments revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Bausch And Lomb Inc

Kala Pharmaceuticals Inc

Pharmos Corp

Hi-Tech Pharmacal Co Inc

Allergan plc

Novartis AG

Eyevance Pharmaceuticals LLC

Pfizer Inc

Horizon Therapeutics plc